European Archives - Page 160 of 1171 - European Medical Journal

The word spotlight on a blue background

Spotlight: January 2025

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in women’s health.

Erratum: Depressive Symptoms and Left Ventricular Diastolic Dysfunction Among Men and Women with HIV

EMJ Allergy and Immunology [Supplement 1] 2025

This symposium review article, covering the symposium at EAACI’s Food Allergy and Anaphylaxis Meeting in Athens, focuses on labelling…

Improving Management of Food Allergy

The symposium was held on the final day of the European Academy of Allergy and Clinical Immunology’s (EAACI) Food Allergy and Anaphylaxis…

IPF Gene Variant May Protect Lungs Post-COVID-19

A recent study has uncovered a new connection between genetic risk factors for idiopathic pulmonary fibrosis and the development of post-COVID-19 lung abnormalities.

Improving Quality of Life in BPH Treatment Advances

Recent advancements in ejaculation-preserving techniques during HoLEP have yielded encouraging results.

Fetuses with Congenital Heart Disease Have Impaired Placental Function and Growth

Reduced placental flow and malperfusion defects in fetuses with CHD highlight potential pathways impacting growth and outcomes.

Charl van Zyl, Lundbeck Pharmaceuticals

Lundbeck’s Charl van Zyl on a new era in neurology

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

Deep-Learning Model for Lung Tumour Detection and Segmentation

Novel deep-learning model has shown promise in identifying and segmenting lung tumours according to new research.

The Role of Antimicrobials and Vaccines in Reducing Dementia Risk

Data review suggests antibiotics, vaccines, and anti-inflammatory drugs reduce dementia risk, advancing drug repurposing opportunities.